Cargando…
Effects of GC7101, a Novel Prokinetic Agent on Gastric Motor Function: Ex Vivo Study
BACKGROUND/AIMS: GC7101, an extract of Lonicera Flos, is a novel developing drug for reflux esophagitis and functional dyspepsia. However, the drug’s exact pharmacological mechanism of action remains unclear. This study assessed the effects of GC7101 on gastrointestinal (GI) motor function. METHODS:...
Autores principales: | Jung, Da Hyun, Choi, Eun Ju, Jeon, Han Ho, Lee, Young Ho, Park, Hyojin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Neurogastroenterology and Motility
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4204422/ https://www.ncbi.nlm.nih.gov/pubmed/25273117 http://dx.doi.org/10.5056/jnm14010 |
Ejemplares similares
-
Prokinetic agents in critical care
por: Doherty, Warren L, et al.
Publicado: (2003) -
Rikkunshito as a Therapeautic Agent for Functional Dyspepsia and its Prokinetic and Non-Prokinetic Effects
por: Inokuchi, Kazumi, et al.
Publicado: (2021) -
Evaluation of prokinetic agents used in the treatment of gastroparesis
por: Roe, Neil A, et al.
Publicado: (2017) -
Effect of DA-9701, a Novel Prokinetic Agent, on Post-operative Ileus in Rats
por: Lee, Sang Pyo, et al.
Publicado: (2017) -
New Developments in Prokinetic Therapy for Gastric Motility Disorders
por: Camilleri, Michael, et al.
Publicado: (2021)